Investment Summary

Adams Street Partners Invests In Atox Bio

On December 4, 2017, asset manager Adams Street Partners invested in life science company Atox Bio

Investment Highlights
  • This is Adams Street Partners’ 16th transaction in the Life Science sector.
  • This is Adams Street Partners’ 101st transaction in the United States.
  • This is Adams Street Partners’ 2nd transaction in North Carolina.

Investment Summary

Date 2017-12-04
Target Atox Bio
Sector Life Science
Investor(s) Adams Street Partners
Deal Type Growth Capital

Target

Atox Bio

Durham, North Carolina, United States
Atox Bio is a late stage biotechnology company that develops novel immunomodulators for critically ill patients. Atox Bio’s lead product, Reltecimod is initially being developed to treat Necrotizing Soft Tissue Infections (NSTI), a rare, life threatening infection for which no therapy currently exists. Atox Bio is based in Durham, North Carolina.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Adams Street Partners

Chicago, Illinois, United States

Investor Investor Investor Investor Investor


Category Asset Manager
Founded 1972
PE ASSETS 60.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Adams Street Partners is a diversified, global investment firm that targets direct, fund of funds, and secondary investments. Adams' direct investing group covers co-investments in buyout transactions, as well as growth equity and venture capital commitments. The direct buyout and growth equity team looks to commit $5 to $30 million per transaction. For venture related investments, commitments of $5 to $20 million are provided to companies in the technology, life sciences and technology enabled services sectors. Typically, target companies have received prior financing from early stage venture firms and are seeking additional capital to fund product development and commercialization. Adams Street Partners was formed in 1972 and is based in Chicago, Illinois.


DEAL STATS #
Overall 112 of 148
Sector (Life Science) 16 of 23
Type (Growth Capital) 11 of 15
State (North Carolina) 2 of 3
Country (United States) 101 of 136
Year (2017) 9 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-11-29 US Med-Equip

Houston, Texas, United States

US Med-Equip is a distributor and rental and related services provider of mission-critical moveable medical equipment used in hospitals. The Company provides equipment rentals across four product categories respiratory, infusion, monitoring, and central supply / NICU. US Med-Equip was founded in 2003 and is based in Houston Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-01 Actium Health

Palo Alto, California, United States

Actium Health is a healthcare CRM platform that transforms healthcare providers into member-focused enterprises. Actium Health was founded in 2014 and is based in Palo Alto, California.

Buy -